Related Experiment Video
Updated: Jan 2, 2026

12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
23.5K
Paediatric Buruli ulcer in Australia.
Georgia Walker1, Deborah N Friedman2, Matthew P O'Brien3
1Department of Paediatrics, Barwon Health, Geelong, Victoria, Australia.
Journal of Paediatrics and Child Health
|December 11, 2019
Summary
Paediatric Buruli ulcer (BU) cases are rising in Australia. Children with BU present differently and have distinct treatment outcomes compared to adults, with higher rates of severe lesions but fewer antibiotic complications.
Area of Science:
- Infectious Diseases
- Paediatric Medicine
- Dermatology
Background:
- Buruli ulcer (BU) is a chronic mycobacterial infection primarily affecting tropical and subtropical regions.
- While predominantly seen in adults, paediatric cases of BU are increasingly reported globally and in Australia.
Purpose of the Study:
- To describe the characteristics of paediatric Buruli ulcer (BU) patients in an Australian cohort.
- To compare the clinical presentation, treatment, and outcomes of paediatric BU cases with adult BU patients.
Main Methods:
- Prospective cohort analysis of all BU cases managed at Barwon Health, Victoria, Australia, from January 1998 to May 2018.
- Patients were categorized into children (≤15 years) and adults (16-64 years and ≥65 years).
- Comparison of lesion types, severity, symptom duration, treatment complications, and cure rates between paediatric and adult cohorts.
Main Results:
- The cohort included 52 paediatric BU patients (9.2%) and 513 adult patients.
- Children exhibited a higher proportion of non-ulcerative (32.7%) and severe lesions (26.9%) compared to adults.
- Paediatric patients had shorter symptom duration before diagnosis and lower rates of antibiotic complications but higher rates of paradoxical reactions.
- High cure rates were observed in both children and adults treated with antibiotics alone or with antibiotics and surgery.
Conclusions:
- Paediatric BU cases are increasing in Australia, forming a significant proportion of the overall BU burden.
- Distinct differences in clinical presentation and treatment outcomes exist between paediatric and adult BU patients in Australia.
- This highlights the need for tailored management strategies for children with Buruli ulcer.
Related Concept Videos
Pulmonary Tuberculosis IV
449
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
449
Pulmonary Tuberculosis V
500
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
500
Pharmacokinetics in Pediatric Patients: Drug Excretion
177
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
177

